Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Sales (2020 - 2025)

Biofrontera (BFRI) has 6 years of Return on Sales data on record, last reported at 0.95% in Q3 2025.

  • For Q3 2025, Return on Sales fell 32.0% year-over-year to 0.95%; the TTM value through Sep 2025 reached 0.47%, down 11.0%, while the annual FY2024 figure was 0.48%, 12.0% up from the prior year.
  • Return on Sales reached 0.95% in Q3 2025 per BFRI's latest filing, down from 0.59% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.57% in Q1 2022 and bottomed at 3.69% in Q3 2021.
  • Average Return on Sales over 5 years is 0.74%, with a median of 0.63% recorded in 2021.
  • Peak YoY movement for Return on Sales: soared 310bps in 2022, then tumbled -166bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 1.58% in 2021, then soared by 83bps to 0.27% in 2022, then soared by 221bps to 0.33% in 2023, then tumbled by -133bps to 0.11% in 2024, then tumbled by -756bps to 0.95% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.95% in Q3 2025, 0.59% in Q2 2025, and 0.49% in Q1 2025.